-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ETCDxeXM7HJx4bjlVnEvok7Hq+tx0RDbtueHiy1+LTtNfUDQ+uQ68N/gNuzGGYna USHEnJAftiQWjRLDiAMT6Q== 0000930413-10-004825.txt : 20100917 0000930413-10-004825.hdr.sgml : 20100917 20100917191243 ACCESSION NUMBER: 0000930413-10-004825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100915 FILED AS OF DATE: 20100917 DATE AS OF CHANGE: 20100917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HORAK IVAN D CENTRAL INDEX KEY: 0001247903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 101079293 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS INC STREET 2: 300 AMERICAN ROD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c62784_ex.xml X0303 4 2010-09-15 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001247903 HORAK IVAN D C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 EVP, R&D, CSO Common Stock 2010-09-15 4 M 0 35000 6.97 A 99888 D Common Stock 2010-09-15 4 M 0 35200 7.14 A 135088 D Common Stock 2010-09-15 4 S 0 57200 10.8077 D 77888 D Common Stock 2010-09-16 4 M 0 2000 7.14 A 79888 D Common Stock 2010-09-16 4 S 0 1700 10.6659 D 78188 D Common Stock 2010-09-17 4 M 0 162800 7.14 A 240988 D Common Stock 2010-09-17 4 M 0 79200 7.40 A 320188 D Common Stock 2010-09-17 4 S 0 200000 10.6333 D 120188 D Employee Stock Option (Right to Buy) 6.97 2010-09-15 4 M 0 35000 0 D 2009-11-23 2015-11-23 Common Stock 35000 0 D Employee Stock Option (Right to Buy) 7.14 2010-09-15 4 M 0 35200 0 D 2009-09-02 2015-09-02 Common Stock 35200 164800 D Employee Stock Option (Right to Buy) 7.14 2010-09-16 4 M 0 2000 0 D 2009-09-02 2015-09-02 Common Stock 2000 162800 D Employee Stock Option (Right to Buy) 7.14 2010-09-17 4 M 0 162800 0 D 2009-09-02 2015-09-02 Common Stock 162800 0 D Employee Stock Option (Right to Buy) 7.40 2010-09-17 4 M 0 79200 0 D 2009-05-18 2016-05-18 Common Stock 79200 66500 D Sales were made solely to pay the exercise price for the options and to satisfy taxes owed in connection with such exercise. Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.76 per share to $10.845 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased or sold at each separate price. Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.66 per share to $10.67 per share. Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.51 per share to $10.71 per share. /s/ Andrew Rackear, Attorney-In-Fact 2010-09-17 -----END PRIVACY-ENHANCED MESSAGE-----